Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29673125
Publication Date : //

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy.


In a previous study, we determined that major pathologic response (MPR) as indicated by the percentage of residual viable tumor cells predicted overall survival (OS) in patients with non-small-cell lung cancer (NSCLC) who received neoadjuvant chemotherapy. In this study, we assessed whether two genes and five protein biomarkers could predict MPR and OS in 98 patients with NSCLC receiving neoadjuvant chemotherapy. We collected formalin-fixed, paraffin-embedded specimens of resected NSCLC tumors from 98 patients treated with neoadjuvant chemotherapy. We identified mutations in KRAS and EGFR genes using pyrosequencing and examined the expression of protein markers VEGFR2, EZH2, ERCC1, RAD51, and PKR using immunohistochemistry. We assessed whether gene mutation status or protein expression was associated with MPR or OS. We observed that KRAS mutation tended to be associated with OS (P = .06), but EGFR mutation was not associated with OS. We found that patients with high RAD51 expression levels had a poorer prognosis than did those with low RAD51 expression. We also observed that RAD51 expression was associated with MPR. MPR and RAD51 expression were associated with OS in univariate and multivariate analyses (P = .04 and P = .02, respectively). Combination of MPR with RAD51 is a significant predictor of prognosis in patients with NSCLC who received neoadjuvant chemotherapy. We demonstrated that MPR or RAD51 expression was associated with OS in patients with NSCLC receiving neoadjuvant chemotherapy. Prediction of a patient's prognosis could be improved by combined assessment of MPR and RAD51 expression.

Authors : Pataer Apar , Shao Ruping , Correa Arlene M , Behrens Carmen , Roth Jack A , Vaporciyan Ara A , Wistuba Ignacio I , Swisher Stephen G ,

Related products :

Catalog number Product name Quantity
Lung - LUC481 Lung cancer array, 16 cases covering all the common types of lung cancer paired with uninvolved lung tissues from the same patients. 2mm
Lung - LUD481 Lung cancer array, 16 cases covering all the common types of lung cancer paired with uninvolved lung tissues from the same patients. 2mm
Multi-MTU241 12 major types of cancer paired with corresponding uninvolved tissues from the same patients. 2.5mm
Multi-MTU391 15 major types of cancer covering top 10 cancers both in the East and West from 12 anatomic sites. Most types have duplicates from different patients with corresponding uninvolved tissues as controls 2.0mm
orb60366 Isotretinoin It was developed to be used as a chemotherapy medication for the treatment of brain cancer, pancreatic cancer and more. For research use only. 1 g
Lung - LUC1502 Lung cancer array, non_overlapping with LUC1501, consists of duplicated 70 cases covering all the common types of lung cancer and 5 cases of normal and other non_malignant lung tissues. 1.1 mm
Lung - LUC961 Lung cancer array consists of duplicated 36 cases covering all the common types of lung cancer and 12 cases of normal and other non_malignant lung tissues. 1.5mm
Lung - LUC1501 Lung cancer array consists of duplicated 70 cases covering all the common types of lung cancer and 5 cases of normal and other non_malignant lung tissues. 1.1 mm
LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases_95 cores
LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases_95 cores; ihc Anti-Cytokeratin (CK) confirmed
GI_Esophagus - ESC241 Esophagus cancer tissue array , 12 cases of esophageal cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2.5mm
GI_Stomach - STC481 Stomach cancer tissue array, 16 cases of gastric cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
E7563h Human Tongue Cancer Chemotherapy Resistance Associ 96T
LUC1504 Lung cancer tissue array (small cell lung cancer), 75 cases, 150 samples (1.1mm), set 4 75 Cases
GI_Esophagus - ESC481 Esophagus cancer tissue array, non_overlapping with ESC241, 24 cases of esophageal cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients. Coming soon. 2mm
Lung - LUC962 Without overlaping with cancer cases in LUC961, LUC962 consists of further 36 cases in duplicates covering all the common types of lung cancer and 12 cases of normal and other non_malignant lung tis 1.5 mm
Cervix - CXC241 Cervix cancer tissue array, 12 cases of cervical cancer paired with corresponding uninvolved tissues from the same patients 2.5mm
Endometrium - EMC241 Endometrium cancer tissue array, 12 cases of endometrial cancer paired with corresponding uninvolved tissues from the same patients 2.5mm
Gl_Rectum - REC481 Rectum cancer tissue array, 16 cases of rectum cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
Gl_Colon - COC481 Colon cancer tissue array, 16 cases of colon cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
LC2085a High_density (188 cases_208 cores), multiple types of lung cancer (I_3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue
LC2085a High-density (188 cases_208 cores), multiple types of lung cancer (I-3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue; ihc Anti-Cytokeratin (CK) confirmed
Liver - LVC481 Liver cancer tissue array, 16 cases of liver cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
Urinary Bladder - BLC241 Bladder cancer tissue array, 12 cases of bladder cancer paired with corresponding uninvolved tissues from the same patients 2.5mm
Breast - BRC481 Breast cancer array, 16 cases of breast cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur